FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034268135> ?p ?o ?g. }

• W2034268135 endingPage "481" @default.
• W2034268135 startingPage "472" @default.
• W2034268135 abstract "The ability of the antitumor immune response to potentiate the therapeutic efficacy of the antiangiogenic agent endostatin was investigated. The antitumor effects of endostatin were tested against weakly immunogenic 3LL Lewis lung carcinoma and its highly immunogenic variant 3LL-C75. Using in vivo Matrigel assay, it was found that the recombinant endostatin produced in the authors' laboratory has a potent antiangiogenic effect. Endostatin manifested a more potent antitumor effect against highly immunogenic 3LL-C75 than weakly immunogenic 3LL tumor. Endostatin induced regression of immunogenic 3LL-C75 tumor in 40% of C57BL/6 mice, whereas partial inhibition and no regression were found in mice bearing weakly immunogenic 3LL tumor. 3LL and 3LL-C75 cells produced similar amounts of Vascular Endothelial Growth Factor, and immunohistochemical analysis revealed that endostatin treatment reduced microvessel density in both 3LL and 3LL-C75 tumors. However, infiltration of T lymphocytes was observed in 3LL-C75 but not in 3LL tumors. These results suggest that the host's immune response may potentiate the antitumor effects of antiangiogenic agents. This possibility was further supported by findings that the antitumor activity of endostatin against 3LL-C75 tumor was lower in immunodeficient than in immunocompetent mice. Stimulation of immune response against 3LL tumor by vaccination with highly immunogenic 3LL-C75 cells substantially increased the antitumor effect of endostatain, resulting in a complete and permanent regression of 3LL tumor in 50% of mice. Tumor vaccination or endostatin treatment applied separately inhibited but did not induce regression of 3LL tumor. These results suggest that the combined attack against tumor cells and the tumor vascular system using antitumor immune mechanisms and antiangiogenic drugs can be a promising strategy for cancer treatment." @default.
• W2034268135 created "2016-06-24" @default.
• W2034268135 creator A5023693660 @default.
• W2034268135 creator A5031217689 @default.
• W2034268135 creator A5032650779 @default.
• W2034268135 creator A5036199580 @default.
• W2034268135 creator A5042253522 @default.
• W2034268135 creator A5047714726 @default.
• W2034268135 creator A5054499936 @default.
• W2034268135 creator A5088924932 @default.
• W2034268135 date "2001-11-01" @default.
• W2034268135 modified "2023-09-22" @default.
• W2034268135 title "Immune Response Against 3LL Lewis Lung Carcinoma Potentiates the Therapeutic Efficacy of Endostatin" @default.
• W2034268135 cites W1528843291 @default.
• W2034268135 cites W1579297325 @default.
• W2034268135 cites W1658047882 @default.
• W2034268135 cites W1970847065 @default.
• W2034268135 cites W1972437692 @default.
• W2034268135 cites W1983806918 @default.
• W2034268135 cites W1997240636 @default.
• W2034268135 cites W2010255761 @default.
• W2034268135 cites W2032106677 @default.
• W2034268135 cites W2036851895 @default.
• W2034268135 cites W2043297474 @default.
• W2034268135 cites W2049909641 @default.
• W2034268135 cites W2072928113 @default.
• W2034268135 cites W2088137443 @default.
• W2034268135 cites W2116293732 @default.
• W2034268135 cites W2131798870 @default.
• W2034268135 cites W2141836567 @default.
• W2034268135 cites W2159133324 @default.
• W2034268135 cites W4230564818 @default.
• W2034268135 doi "https://doi.org/10.1097/00002371-200111000-00004" @default.
• W2034268135 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11759070" @default.
• W2034268135 hasPublicationYear "2001" @default.
• W2034268135 type Work @default.
• W2034268135 sameAs 2034268135 @default.
• W2034268135 citedByCount "19" @default.
• W2034268135 countsByYear W20342681352016 @default.
• W2034268135 countsByYear W20342681352020 @default.
• W2034268135 countsByYear W20342681352022 @default.
• W2034268135 crossrefType "journal-article" @default.
• W2034268135 hasAuthorship W2034268135A5023693660 @default.
• W2034268135 hasAuthorship W2034268135A5031217689 @default.
• W2034268135 hasAuthorship W2034268135A5032650779 @default.
• W2034268135 hasAuthorship W2034268135A5036199580 @default.
• W2034268135 hasAuthorship W2034268135A5042253522 @default.
• W2034268135 hasAuthorship W2034268135A5047714726 @default.
• W2034268135 hasAuthorship W2034268135A5054499936 @default.
• W2034268135 hasAuthorship W2034268135A5088924932 @default.
• W2034268135 hasConcept C121608353 @default.
• W2034268135 hasConcept C126322002 @default.
• W2034268135 hasConcept C154317977 @default.
• W2034268135 hasConcept C202751555 @default.
• W2034268135 hasConcept C203014093 @default.
• W2034268135 hasConcept C2777701055 @default.
• W2034268135 hasConcept C2777847059 @default.
• W2034268135 hasConcept C2779013556 @default.
• W2034268135 hasConcept C2780394083 @default.
• W2034268135 hasConcept C502942594 @default.
• W2034268135 hasConcept C55493867 @default.
• W2034268135 hasConcept C71924100 @default.
• W2034268135 hasConcept C75920679 @default.
• W2034268135 hasConcept C86803240 @default.
• W2034268135 hasConcept C8891405 @default.
• W2034268135 hasConcept C98274493 @default.
• W2034268135 hasConceptScore W2034268135C121608353 @default.
• W2034268135 hasConceptScore W2034268135C126322002 @default.
• W2034268135 hasConceptScore W2034268135C154317977 @default.
• W2034268135 hasConceptScore W2034268135C202751555 @default.
• W2034268135 hasConceptScore W2034268135C203014093 @default.
• W2034268135 hasConceptScore W2034268135C2777701055 @default.
• W2034268135 hasConceptScore W2034268135C2777847059 @default.
• W2034268135 hasConceptScore W2034268135C2779013556 @default.
• W2034268135 hasConceptScore W2034268135C2780394083 @default.
• W2034268135 hasConceptScore W2034268135C502942594 @default.
• W2034268135 hasConceptScore W2034268135C55493867 @default.
• W2034268135 hasConceptScore W2034268135C71924100 @default.
• W2034268135 hasConceptScore W2034268135C75920679 @default.
• W2034268135 hasConceptScore W2034268135C86803240 @default.
• W2034268135 hasConceptScore W2034268135C8891405 @default.
• W2034268135 hasConceptScore W2034268135C98274493 @default.
• W2034268135 hasIssue "6" @default.
• W2034268135 hasLocation W20342681351 @default.
• W2034268135 hasLocation W20342681352 @default.
• W2034268135 hasOpenAccess W2034268135 @default.
• W2034268135 hasPrimaryLocation W20342681351 @default.
• W2034268135 hasRelatedWork W1978929016 @default.
• W2034268135 hasRelatedWork W1996150995 @default.
• W2034268135 hasRelatedWork W2057608106 @default.
• W2034268135 hasRelatedWork W2259809757 @default.
• W2034268135 hasRelatedWork W2351251863 @default.
• W2034268135 hasRelatedWork W2351637413 @default.
• W2034268135 hasRelatedWork W2374840739 @default.
• W2034268135 hasRelatedWork W2385835918 @default.
• W2034268135 hasRelatedWork W2392761316 @default.
• W2034268135 hasRelatedWork W2890462578 @default.
• W2034268135 hasVolume "24" @default.

• next